Accreditation
EBAC
Language
English
Login
We offer our registered users tailored information, free online courses and exclusive content.
Can't find your password?
Reset it here.
Reset it here.
6th EMEA forum on cardiovascular risks
6th EMEA forum on cardiovascular risks
- Hypertension
Saturday, Nov 18 2017
Lisbon, Portugal
Registration status
Closed
Target audiences
Cardiologists and internists involved in preventing and managing patients with cardiovascular risk factors or who are experiencing cardiovascular diseases.
Files
Introduction
Access learning resources by clicking the Outcomes tab or scroll down to the Scientific Programme.
Overview
This live educational conference will look at available evidence on specific and relevant topics related to cardiovascular disease. Discussion will focus on increased sympathetic activity in the pathogenesis of hypertension-related heightened cardiovascular risk and the need to consider high heart rate as a target for treatment. The role of combination treatment in hypertension and recent novelties in the availability of fixed dose formulations will also be addressed. Treating the main hypertension - related clinical conditions, including acute coronary syndrome and heart failure, will also be discussed. Another major topic of interest will be to the optimal timeline for treating diabetic patients with beta-blockers and if there are differences among different molecules of this class.
Time will also be dedicated to interactive clinical case discussions which will translate results from controlled clinical trials and guidelines into applications for daily clinical practice.
Learning objectives
By attending this live educational programme, participants will be able to:
• Highlight sympathetic nervous system over activity as a pathogenetic mechanism in hypertensive-related cardiovascular risk and discuss if this parameter can be considered a target in antihypertensive treatment
• Discuss the role of fixed dose combinations in the treatment of hypertension and address the therapeutic relevance of the new fixed dose combination beta-blocker/calcium antagonist
• Identify the best practice according to guidelines for treating hypertensive patients with coronary artery disease
• Manage the complex transition from hypertension to heart failure and discuss the possible beneficial effect of pharmacological
treatment
• Select the best beta-blocker compound when treating patients with diabetes
Accreditation details
An application will be made to the European Board for Accreditation in Cardiology (EBAC) for CME accreditation of the “6th EMEA forum on cardiovascular risks”, to be held on 18 November 2017 in Lisbon, Portugal.
Scientific programme
Saturday, 18 November 2017
08.20 Opening and introduction
G. Mancia (Italy)
Session I
08.30 L1 Sympathetic nervous system and cardiovascular risk VIDEO LECTURE
G. Mancia (Italy)
08.50 L2 Should increased heart rate be considered a target in cardiovascular treatment? VIDEO LECTURE
H. A.J. Struijker-Boudier (The Netherlands)
09.10 L3 New possibilities for the fixed-dose combination treatment in hypertension VIDEO LECTURE
S. Taddei (Italy)
09.30 Panel discussion
09.50 Coffee break
Session II
10.10 L4 Best practice in the management of stable chronic angina VIDEO LECTURE
B. Tomlinson (Hong Kong)
10.30 L5 From hypertension to heart failure: prevention strategies VIDEO LECTURE
E. Erdmann (Germany)
10.50 L6 Use of betablockers in diabetes VIDEO LECTURE
G. Grassi (Italy)
11.10 Panel discussion
Session III
11.30 Working groups
This session includes two different parallel workshops, each lasting 1 hour. Participants will be divided into groups and will attend both workshops in rotation. By the end of the session each participant will have attended both workshops.
WG1 The role of beta-blockers in hypertensive patients
Presenter: H. A.J. Struijker-Boudier (The Netherlands)
Discussant: B. Tomlinson (Hong Kong)
WG2 How to optimize treatment in patients with heart failure
Presenter: E. Erdmann (Germany)
Discussant: S. Taddei (Italy)
13.30 Take home messages from the working groups and wrap up
13.50 Closing remarks
G. Mancia (Italy)
14.00 End of the workshop
Closing lunch
CME provider
EXCEMED - Excellence in Medical Education
Chair(s)
Giuseppe Mancia
Department of Clinical Medicine
University of Milano-Bicocca
Milan, Italy
Speakers
Harry Struijker-Boudier
Department of Cardiovascular Research
Maastricht University
Maastricht, Netherlands
Stefano Taddei
Department of Clinical and Experimental Medicine
Hypertension Unit
University of Pisa
Pisa, Italy
Brian Tomlinson
Specialist in Internal Medicine & Clinical Pharmacology
Department of Medicine and Therapeutics
Adjunct Professor
The Chinese University of Hong Kong
Hong Kong, China
Giuseppe Mancia
Department of Clinical Medicine
University of Milano-Bicocca
Milan, Italy
Erland Erdmann
Department of Cardiology
University of Köln
Köln, Germany
Guido Grassi
Department of internal medicine
University of Milano-Bicocca
Milan, Italy
Registration/Accommodation
The registration fee is 150€ and includes:
• Access to scientific sessions
• Educational materials
• Certificate of attendance
• Coffee break and luncheons
Dinners are not included.
Disclaimer
Cardiometabolic
Video
Cardiometabolic
Video
Cardiometabolic
Video
Cardiometabolic
Cardiometabolic
Cardiometabolic
Slide kit
Cardiometabolic
Slide kit
Cardiometabolic
Video
Cardiometabolic
Cardiometabolic
